Advertisement
Research Article| Volume 16, ISSUE 2, P377-394, June 1996

Alcohol and Other Chemicals in the Development of Hepatocellular Carcinoma

  • Farber Emmanuel
    Correspondence
    Address reprint requests to: Emmanuel Färber, MD, PhD, Department of Pathology, Anatomy, and Cell Biology, Thomas Jefferson University, 212B Jefferson Alumni Hall, 1020 Locust Street, Philadelphia, PA 19107–6799
    Affiliations
    From the Department of Pathology, Anatomy, and Cell Biology, Thomas Jefferson University, Philadelphia, Pennsylvania
    Search for articles by this author
DOI:https://doi.org/10.1016/S0272-2712(18)30275-0
Alcohol and Other Chemicals in the Development of Hepatocellular Carcinoma
Previous ArticleHepatic Fibrogenesis
Next ArticleHepatitis B and C Viruses and Hepatocellular Carcinoma
      This paper is only available as a PDF. To read, Please Download here.
      The possible roles of alcohol (ethanol) as a carcinogen and as a modulator of the carcinogenic process are reviewed. The effects of alcohol are compared with those of well-known genotoxic and nongenotoxic or epigenetic carcinogens in their roles in the genesis of hepatocellular carcinomas. Also, the effects of alcohol are compared with those of known promoting agents for the liver. In addition, the possible roles of alcohol in the genesis of the potential precancerous liver lesions, in cirrhosis, and in the modulation of cancer induction with the known carcinogenic influences, hepatitis B and C viruses, are analyzed. The possible role of alcohol in the modulation of liver cell membrane lesions in the development of liver cell cancer is explored.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Adami H-O
        • Hsing A.W.
        • McLaughlin J.K.
        • et al.
        Alcoholism and liver cirrhosis in the etiology of primary liver cancer.
        Int J Cancer. 1992; 51: 898
        • Arico S.
        • Corrao G.
        • Torchio P.
        • et al.
        A strong negative association between alcohol consumption and the risk of hepatocellular carcinoma in cirrhotic patients. A case-control study.
        Eur J Epidemiol. 1994; 10: 251
        • Babinet C.
        • Farza H.
        • Morello D.
        • et al.
        Specific expression of hepatitis B surface antigen (HBsAg) in transgenic mice.
        Science. 1985; 230: 1160
        • Bellentani S.
        • Tiribelli C.
        • Saccoccio G.
        • et al.
        Prevalence of chronic liver disease in the general population of Northern Italy: The dionysos study.
        Hepatology. 1994; 20: 1442
        • Blot W.J.
        Alcohol and cancer.
        Cancer Res. 1992; 52: 2119S
        • Blumberg B.S.
        • London W.T.
        Hepatitis B virus: Pathogenesis and prevention of primary cancer of the liver.
        Cancer. 1982; 50: 2657
        • Boule C.
        • Nagai M.K.
        • Montalvo M.
        • et al.
        Modulation of the hepatocarcinogenic process by clofibrate and WY 14,043.
        Proc Am Assoc Cancer Res. 1995; 36: 1060
        • Brechot C.
        • Nalpas B.
        • Courouce A-M
        • et al.
        Evidence that hepatitis B virus has a role in liver-cell carcinoma in alcoholic liver disease.
        N Engl J Med. 1982; 306: 1384
        • Caporaso N.
        • Romano M.
        • deSio I.
        • et al.
        Hepatitis C virus infection is an additive factor for development of hepatocellular carcinoma in patients with cirrhosis.
        J Hepatol. 1991; 12: 367
        • Cattley R.C.
        • Marsman D.S.
        • Popp J.A.
        Failure of the peroxisome proliferator Wy-14,643 to initiate-growth-selectable foci in rat liver.
        Toxicology. 1989; 56: 1
        • Cerutti P.A.
        Prooxidant states and tumor promotion.
        Science. 1985; 227: 375
        • Chisari F.V.
        • Filippi P.
        • Buras J.
        • et al.
        Structural and pathological effects of synthesis of hepatitis B virus large envelope polypeptide in transgenic mice.
        Proc Natl Acad Sei USA. 1987; 84: 6909
        • Chisari F.V.
        • Filippi P.
        • McLachlan A.
        • et al.
        Expression of hepatitis B virus large envelope polypeptide inhibits hepatitis B surface antigen secretion in transgenic mice.
        J Virol. 1986; 60: 880
        • Chisari F.V.
        • Pinkert C.A.
        • Milich D.R.
        • et al.
        A transgenic mouse model of the chronic hepatitis B surface antigen carrier state.
        Science. 1985; 230: 1157
        • Chisari F.V.
        • Klopchin K.
        • Moriyama T.
        • et al.
        Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice.
        Cell. 1989; 59: 1145
        • Conway J.G.
        • Cattley R.C.
        • Popp J.A.
        • et al.
        Possible mechanisms in hepatocarcinogenesis by the peroxisome proliferator di(2-ethylhexyl) phthalate.
        Drug Metab Rev. 1989; 21: 65
        • Epstein S.
        • Ito N.
        • Merkow L.
        • et al.
        Cellular analysis of liver carcinogenesis: The induction of large hyperplastic modules in the liver with 2-fluorenylacetamide or ethionine and some aspects of their morphology and glycogen metabolism.
        Cancer Res. 1967; 27: 1702
        • Eriksson S.
        • Carlson J.
        • Velez R.
        Risk of cirrhosis and primary liver cancer in alpha-1-antitrypsin deficiency.
        N Engl J Med. 1986; 314: 736
        • Färber E.
        Ethionine carcinogenesis.
        Adv Cancer Res. 1963; 7: 383
        • Färber E.
        Sequential events in chemical carcinogenesis.
        in: Becker FF Cancer: A Comprehensive Treatise, ed 2, vol 1. Plenum, New York1982: 485
        • Färber E.
        Clonal adaptation during carcinogenesis.
        Biochem Pharmacol. 1990; 39: 1837
        • Färber E.
        Cell proliferation as a major risk factor for carcinogenesis. A concept of doubtful validity.
        Cancer Res. 1995; 55: 3759
        • Färber E.
        • Sarma D.S.R.
        Biology of disease: Hepatocarcinogenesis. A dynamic cellular perspective.
        Lab Invest. 1987; 56: 4
        • Farinati F.
        • Salvagnini M.
        • Garro A.J.
        • et al.
        Ethanol and carcinogenesis: Promoter, cocarcinogen or innocent bystander?.
        Ital J Gastroenterol. 1988; 20: 322
        • Feitelson M.A.
        Hepatitis Bx antigen in the pathogenesis of hepatocellular carcinoma [review].
        Oncol Rev. 1995; 2: 193
        • Foulds L.
        Neoplastic Development, vol 2. Academic Press, London1975
        • Garvey L.K.
        • Swenberg J.A.
        • Hamm T.E.
        • et al.
        Di(2-ethylhexyl) phthalate lack of initiating activity in the liver of female F-344 rats.
        Carcinogenesis. 1987; 8: 285
        • Geller S.A.
        • Nichols W.S.
        • Kim S.S.
        • et al.
        Hepatocarcinogenesis is the sequel to hepatitis in alpha 1-antitrypsin transgenic mice. Histopathological and DNA ploidy studies.
        Hepatology. 1994; 91: 389
        • Gerber M.A.
        • Hadziyannis S.
        • Vissoulis C.
        • et al.
        Electron microscopy and immunoelec-tronmicroscopy of cytoplasmic hepatitis B antigen in hepatocytes.
        Am J Pathol. 1974; 75: 489
        • Gerber M.A.
        • Krawezynski K.
        • Alter M.J.
        • et al.
        Histopathology of community acquired chronic hepatitis C.
        Mod Pathol. 1992; 5: 483
        • Gindi T.
        • Ghazarian D.M.D.
        • Deitch D.
        • et al.
        An origin of presumptive preneoplastic foci and nodules from hepatocytes in chemical carcinogenesis in the rat.
        Cancer Lett. 1994; 83: 75
        • dauert H.P.
        • Clark T.D.
        Lack of initiating activity of the peroxisome proliferator ciprofibrate in two-stage carcinogenesis.
        Cancer Lett. 1989; 43: 95
        • Goldfarb S.
        A morphological and histochemical study of carcinogenesis of the liver in rats fed 3′-methyl-4’-dimethylaminoazobenzene.
        Cancer Res. 1973; 33: 1119
        • Gordon J.W.
        Transgenic mouse models of hepatocellular carcinoma.
        Hepatology. 1994; 19: 538
        • Greaves P.
        • Irisarri E.
        • Munro A.M.
        Hepatic foci of cellular and enzymatic alteration and nodules in rats treated with clofibrate or diethylnitrosamine followed by pheno-barbital: Their rate of onset and their reversibility.
        J Natl Cancer Invest. 1986; 76: 475
        • Guyton K.Z.
        • Kensler T.W.
        Oxidative mechanisms in carcinogenesis.
        Br Med Bull. 1993; 49: 523
        • Harris C.C.
        Solving the viral-chemical puzzle of human liver carcinogenesis.
        Cancer Epidemiol Biomarkers Prev. 1994; 3: 1
        • Hoek J.B.
        Mitochondrial energy metabolism in chronic alcoholism.
        Curr Topics Bioen-erget. 1994; 17: 197
        • Hoek J.B.
        • Taraschi T.F.
        • Rubin E.
        Functional implications of the interaction of ethanol with biologic membranes: Actions of ethanol on hormonal signal transduction systems.
        Semin Liver Dis. 1988; 8: 36
        • Hoek J.B.
        • Taraschi T.F.
        Cellular adaptation to ethanol.
        Trends Biochem Sei. 1988; 13: 269
        • Hoek T.B.
        • Thomas A.P.
        • Rooney T.A.
        • et al.
        Ethanol and signal transduction in the liver.
        FASEB J. 1992; 6: 2386
        • Huang S-N
        • Groh V.
        Immunoagglutination electron microscopic study on virus-like particles and Australia antigen in liver tissue.
        Lab Invest. 1973; 29: 353
        • Huang S-N
        • Millman I.
        • O’Connell A.
        Virus-like particles in Australia antigen-associated hepatitis. An immunoelectron microscopic study of human liver.
        Am J Pathol. 1972; 67: 453
        • IARC
        Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans: Allyl Compounds, Aldehydes, Epoxides and Peroxides, vol 36. IARC, Lyon1985
        • IARC
        Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Humans. Overall Evaluation: An updating of IARC Monographs vols 1 to 42; suppl 7. IARC, Lyon1987
        • IARC
        Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Humans. Alcohol Drinking, vol 44. IARC, Lyon1988
        • IARC
        Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Humans. Hepatitis Viruses, vol 59. IARC, Lyon1994
        • Ishak K.G.
        Chronic hepatitis: Morphology and nomenclature.
        Mod Pathol. 1994; 7: 690
        • Lieber C.S.
        Biochemical and molecular basis of alcohol-induced injury to liver and other tissues.
        N Engl J Med. 1988; 319: 1639
        • Lieber C.S.
        Mechanism of ethanol induced hepatic injury.
        Pharmacol Ther. 1990; 46: 1
        • London W.T.
        • Blumberg B.S.
        A cellular model of the role of HBV in the pathogenesis of primary hepatocellular carcinoma.
        Hepatology. 1982; 2: 105
        • London W.T.
        • Blumberg B.S.
        Hepatitis B virus and primary hepatocellular carcinoma.
        in: Burchinal JH Oettgen HF Cancer Achievements, Challenges and Prospects for the 1980’s. Grune & Stratton, New York1981: 161
        • Meyer M.
        • Caselmann W.H.
        • Schlüter V.
        • et al.
        Hepatitis B virus transactivator MHBs: Activation of NF-xB, selective inhibition by antioxidants and integral membrane localization.
        EMBO J. 1992; 11: 2991
        • Moody D.E.
        • Reddy J.K.
        • Lake B.G.
        • et al.
        Peroxisome proliferation and nongenotoxic carcinogens: Commentary on a symposium.
        Fund Appl Toxicol. 1991; 16: 233

      55. Nagai MK: The biochemical pathology of liver cancer development with the nongenotoxic carcinogen clofibrate [post doctoral thesis]. University of Toronto, 1993

        • Nagai M.K.
        • Prior L.
        • Färber E.
        Possible mechanisms of tumor promotion by the nongenotoxic carcinogen clofibrate.
        Proc Am Assoc Cancer Res. 1994; 35: 1004
        • Nalpas B.
        • Feitelson M.
        • Brechot C.
        • et al.
        Alcohol, hepatotropic viruses and hepatocellular carcinoma.
        Alcohol Clin Exp Res. 1995; 19: 1089
        • Naccarato R.
        • Farinati F.
        Hepatocellular carcinoma, alcohol and cirrhosis: Facts and hypotheses.
        Dig Dis Sei. 1991; 36: 1137
        • Ohsima H.
        • Bartsch H.
        Chronic infections and inflammatory processes as cancer risk factors: Possible role of nitric oxide in carcinogenesis.
        Mutat Res. 1994; 305: 253
        • Okuda K.
        Epidemiology of primary liver cancer.
        in: Tobe T Kameda H Okudiara M Primary Liver Cancer in Japan. Springer-Verlag, Tokyo1992: 3
        • Popper H.
        Changing concepts of the evolution of chronic hepatitis and the role of piecemeal necrosis.
        Hepatology. 1983; 3: 758
        • Popper H.
        • Shafritz D.A.
        • Hoofnagle J.H.
        Relation of the hepatitis B virus carrier state to hepatocellular carcinoma.
        Hepatology. 1987; 7: 767
        • Popper H.
        • Sternberg S.S.
        • Oser B.C.
        • et al.
        The carcinogenic effect of aramite in rats. A study of hepatic nodules.
        Cancer. 1960; 13: 1035
        • Prehn R.T.
        A clonal selection theory of chemical carcinogenesis.
        J Natl Cancer Inst. 1964; 32: 1
        • Pugh T.D.
        • Goldfarb S.
        Quantitative histochemical and autoradiographic studies of hepatocarcinogenesis in rats fed 2-acetylaminofluorene followed by phenobarbital.
        Cancer Res. 1978; 38: 4450
        • Rao M.S.
        • Reddy J.K.
        Phenotypic properties of preneoplastic and neoplastic hepatic lesions induced by peroxisome proliferators in rats.
        in: Fahimi HD Sies H Peroxisomes in Biology and Medicine. Springer-Verlag, Berlin1987: 263
        • Reddy J.K.
        • Lalwani N.D.
        Carcinogenesis by hepatic peroxisome proliferators evaluation of the risk of hypolipidemic drugs and industrial plasticizers to humans.
        CRC Rev Toxicol. 1983; 12: 1
        • Rubin E.
        The chemical pathogenesis of alcohol-induced tissue injury.
        Alcohol Health Res World. 1993; 17: 272
        • Rubin H.
        Spontaneous transformation as aberrant epigenesis.
        Differentiation. 1993; 53: 123
        • Scherer E.
        • Emmelot P.
        Kinetics of evolution and growth of precancerous livercell foci and liver tumor formation by diethylnitrosamine in the rat.
        Eur J Cancer. 1975; 11: 689
        • Scheuer P.J.
        • Ashrafzadeh P.
        • Sherlock S.
        • et al.
        The pathology of hepatitis C.
        Hepatology. 1992; 15: 567
        • Schreck R.
        • Rieber P.
        • Baeuerle P.A.
        Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-xB transcription factor and HIV-1.
        EMBO J. 1991; 10: 2247
        • Shimizu S.
        • Kiyosawa K.
        • Sodeyama T.
        • et al.
        High prevalence of antibody of hepatitis C virus in heavy drinkers with chronic liver disease in Japan.
        J Gastroenterol Hepatol. 1992; 7: 30
        • Solt D.B.
        • Färber E.
        A new principle for the analysis of chemical carcinogenesis.
        Nature. 1976; 263: 702
        • Solt D.B.
        • Medline A.
        • Färber E.
        Rapid emergence of carcinogen-induced hyperplastic lesions in a new model for the sequential analysis of liver carcinogenesis.
        Am J Pathol. 1977; 88: 595
        • Stein O.
        • Fainaru M.
        • Stein Y.
        Visualization of virus-like particles in endoplasmic reticulum of hepatocytes of Australia antigen carriers.
        Lab Invest. 1972; 26: 262
        • Takada A.
        • Nei J.
        • Takase S.
        • et al.
        Effects of ethanol on experimental hepatocarcinogenesis.
        Hepatology. 1986; 6: 65
        • Taraschi T.F.
        • Rubin E.
        Biology of disease: Effects of ethanol on the chemical and structural properties of biological membranes.
        Lab Invest. 1985; 52: 120
        • Taraschi T.F.
        • Rubin E.
        The interaction of ethanol with biological membranes: An overview.
        in: Färber E Phillips MJ Kaufman N Pathogenesis of Liver Disease. International Academy of Pathology. Monographs in Pathology, no 28. Williams & Wilkins, Baltimore1987: 113
        • Tsuda H.
        • Lee G.
        • Färber E.
        Induction of resistant hepatocytes as a new principle for a possible short-term in vivo test for carcinogens.
        Cancer Res. 1980; 40: 1157
        • Wogan G.N.
        Aflatoxins as risk factors for hepatocellular carcinoma in humans.
        Cancer Res. 1992; 52: 2114s

      Article info

      Identification

      DOI: https://doi.org/10.1016/S0272-2712(18)30275-0

      Copyright

      © 1996 Elsevier Inc. Published by Elsevier Inc. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX